Cushing Syndrome Clinical Trials

52 clinical trials for Cushing Syndrome across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome — RECRUITING · PHASE2
• Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases — RECRUITING
• NAC- NAFLD And Cushing — RECRUITING · NA
• A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome — RECRUITING · PHASE1
• Adrenal Tumors - Pathogenesis and Therapy — RECRUITING
• Adrenal stress response upon stimulation with ACTH in healthy subjects and in patients with Cushing's disease in remission — RECRUITING
• Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome — RECRUITING · PHASE2
• Institutional Registry of Rare Diseases — RECRUITING
• Collecting Information About Treatment Results for Patients With Cushing's Syndrome — RECRUITING
• Establishment and Clinical Application of Reference Intervals of Salivary Cortisol — RECRUITING
• Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS) — RECRUITING
• Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT — RECRUITING
• Cushing's Syndrome Before and After Treatment (CORRECT) — RECRUITING
• Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome — RECRUITING · PHASE4
• A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery — RECRUITING · NA
• Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism — RECRUITING · NA
• A Prospective Cohort Study for Patients With Adrenal Diseases — RECRUITING
• Specificity of the saliva cortisol measurements in patients with obesity and development of a weight-dependent threshold value for the saliva cortisol for obese patients with a BMI > 35 for better early detection of Cushingsyndroms — RECRUITING
• Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome — ACTIVE_NOT_RECRUITING · PHASE2
• A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy and Safety of Fluasterone Buccal Tablet in the Control of Hyperglycemia in Adults with Endogenous Cushing’s Syndrome — TERMINATED · PHASE2
• Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome — NOT_YET_RECRUITING · PHASE4
• A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome — COMPLETED · PHASE3
• Open-label Treatment in Cushing's Syndrome — COMPLETED · PHASE3
• Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders — NOT_YET_RECRUITING · NA
• Quality of Life, Fatigue and Cognitive, Affective and Emotional Dysfunction in Patients With Cushing's Syndrome — ACTIVE_NOT_RECRUITING
• Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models — NOT_YET_RECRUITING
• Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data — OTHER
• Dynamic Hormone Diagnostics in Endocrine Disease — COMPLETED
• Metabolic Myopathy in Endocrinopathy — TERMINATED
• Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy — OTHER
• Real-time Monitoring of Cortisol - Comparison of Cortisol Levels in Four Biological Fluids — OTHER
• Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants — COMPLETED · PHASE1
• Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders — OTHER · NA
• The Circadian Rhythm in CusHing SyndrOme in Active Phase and dUring RemiSsion (TheHOURS) — OTHER
• Appropriate Limit Value for 1 mg DST in Patients With Chronic Renal Failure — COMPLETED
• Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole. — OTHER
• China Adrenal Disease Registry — OTHER
• New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome — COMPLETED · PHASE2
• A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome — TERMINATED · PHASE2
• Nailfold Capillaroscopy Evaluation in Cushing Syndrome Patients — OTHER
• Liquorice and Salivary Cortisol — OTHER · NA
• Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome — TERMINATED
• Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma — OTHER · NA
• Muscle in Acromegaly and Cushing's Syndrome — OTHER
• The Accuracy of Late Night Urinary Free Cortisol/Creatinine and Hair Cortisol in Cushing's Syndrome Diagnosis — OTHER
• Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism — TERMINATED · PHASE2
• Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids — COMPLETED
• Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma — OTHER · PHASE2
• Efficacy and Safety of Posterior Retroperitoneoscopic Adrenalectomy: A Comparative Study — COMPLETED · NA
• Adrenal Venous Sampling in Patients With Overt or Subclinical Cushings Syndrome, and Bilateral Adrenal Tumors — OTHER · NA

Refine this search